Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas

[1]  M. Nourbakhsh,et al.  Up-regulation of 15-lipoxygenase enzymes and products in functional and non-functional pituitary adenomas , 2019, Lipids in Health and Disease.

[2]  Simion I. Chiosea,et al.  Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer , 2019, The Journal of experimental medicine.

[3]  O. Pînzariu,et al.  Metabolomics—A Promising Approach to Pituitary Adenomas , 2019, Front. Endocrinol..

[4]  C. Fernandes,et al.  Tumor Microenvironment Targeted Nanotherapy , 2018, Front. Pharmacol..

[5]  M. Coluccia,et al.  Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature , 2018, Pharmaceuticals.

[6]  M. Korbonits,et al.  Clinical and Pathological Aspects of Silent Pituitary Adenomas , 2018, The Journal of clinical endocrinology and metabolism.

[7]  Q. Luo,et al.  Decreased expression level and DNA-binding activity of specificity protein 1 via cyclooxygenase-2 inhibition antagonizes radiation resistance, cell migration and invasion in radiation-resistant lung cancer cells , 2018, Oncology letters.

[8]  E. Laws,et al.  Management of non-functioning pituitary adenomas: surgery , 2018, Pituitary.

[9]  W. Zhou,et al.  COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment , 2018, Clinical Cancer Research.

[10]  F. Lammert,et al.  Preservation of hormonal function by identifying pituitary gland at endoscopic surgery , 2017, Journal of Clinical Neuroscience.

[11]  E. Faghihloo,et al.  Evaluation of the expression level of 12/15 lipoxygenase and the related inflammatory factors (CCL5, CCL3) in respiratory syncytial virus infection in mice model. , 2017, Microbial pathogenesis.

[12]  S. Swarnakar,et al.  Regulation of Matrix Metalloproteinase-2 Activity by COX-2-PGE2-pAKT Axis Promotes Angiogenesis in Endometriosis , 2016, PloS one.

[13]  N. Sharma-Walia,et al.  Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis , 2016, Oncotarget.

[14]  G. Meresman,et al.  Enhanced cyclooxygenase-2 expression levels and metalloproteinase 2 and 9 activation by Hexachlorobenzene in human endometrial stromal cells. , 2016, Biochemical pharmacology.

[15]  F. Rezaei,et al.  A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer? , 2016, Tumor Biology.

[16]  Bing Liu,et al.  Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity , 2015, Cancer Cell International.

[17]  Erik Sahai,et al.  Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity , 2015, Cell.

[18]  Cheng-Wei Tang,et al.  [The Expressions of Somatostatin and Cycloxygenase-2 in Chronic Hepatitis, Hepatic Cirrhosis, Precancerous Lesion and Hepatocellular Carcinoma]. , 2015, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[19]  L. Vermeulen,et al.  Cancer heterogeneity—a multifaceted view , 2013, EMBO reports.

[20]  D. Rosenberg,et al.  Multifaceted roles of PGE2 in inflammation and cancer , 2013, Seminars in Immunopathology.

[21]  A. Hubalewska-Dydejczyk,et al.  Expression of cyclooxygenase-2 (COX-2) in pituitary tumours , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[22]  L. Ghibelli,et al.  The Role of Cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies , 2010, International journal of cell biology.

[23]  J Pammer,et al.  Strong evidence for up‐regulation of cyclooxygenase‐1 in head and neck cancer , 2007, European journal of clinical investigation.

[24]  B. Scheithauer,et al.  Pathobiology of Pituitary Adenomas and Carcinomas , 2006, Neurosurgery.

[25]  T. Yamaki,et al.  Prostaglandin E2 activates Src signaling in lung adenocarcinoma cell via EP3. , 2004, Cancer letters.

[26]  B. Scheithauer,et al.  Cyclooxygenase‐2 expression in human pituitary tumors , 2003, Cancer.

[27]  S. Yamashina,et al.  Cyclo‐oxygenase‐2 enhances basic fibroblast growth factor‐induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants , 2000, British journal of pharmacology.

[28]  P. Lipsky,et al.  Cyclooxygenase in biology and disease , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  J. Morrow,et al.  Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. , 1998, Cancer research.

[30]  Kang Yang,et al.  Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis. , 2019, Cancer letters.

[31]  Chunjiang Tan,et al.  Serum ubiquitin via CXC chemokine receptor 4 triggered cyclooxygenase-1 ubiquitination possibly involved in the pathogenesis of aspirin resistance. , 2015, Clinical hemorheology and microcirculation.

[32]  Zhi-mao Jiang,et al.  Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[33]  J. Kaur,et al.  Induction of apoptosis as a potential chemopreventive effect of dual cycloxygenase inhibitor, diclofenac, in early colon carcinogenesis. , 2010, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[34]  W. Neuhofer,et al.  PGE2 potentiates tonicity-induced COX-2 expression in renal medullary cells in a positive feedback loop involving EP2-cAMP-PKA signaling. , 2009, American journal of physiology. Cell physiology.

[35]  B. Scheithauer,et al.  Analysis of Cox-2 and thromboxane synthase expression in pituitary adenomas and carcinomas , 2004, Endocrine pathology.

[36]  G. Kontogeorgos,et al.  Correlation of Bcl-2 and Bax with Apoptosis in Human Pituitary Adenomas , 2004, Pituitary.

[37]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[38]  T. Nose,et al.  Expression of P27kip 1 and Ki-67 in Pituitary Adenomas: An Investigation of Marker of Adenoma Invasiveness , 1999, Acta Neurochirurgica.

[39]  R. Kurumbail,et al.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1996, Nature.

[40]  S. Kanematsu,et al.  Effects of pituitary adenylate cyclase-activating polypeptide (PACAP), prostaglandin E2 (PGE2) and growth hormone releasing factor (GRF) on the release of growth hormone from cultured bovine anterior pituitary cells in vitro. , 1994, Domestic animal endocrinology.